Alan Piper is a maverick historian of ideas with a penchant for unique, deep dives into rich veins of psychedelia. Piper’s 2015 monograph, Strange Drugs Make for Bedfellows: Ernst Jünger, Albert Hofmann, and the Politics of Psychedelics was foundational for the critique explored in Brian Pace’s controversial Lucy in the Sky with Nazis: Psychedelics and the Right Wing. In this interview, Pace interviews Piper about Hofmann tripping buddy and Wehrmacht Captain Jünger, LSD and ideology— clarifying concepts and dispelling myths.

In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the "psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization of a "capitalist animism"—treating social phenomena like markets or financial capital as living entities—that fixates on "economic health" at the expense of public health. As this unprecedented situation continues to unfold, we explore some considerations for this sudden period of social isolation within a broader culture of social alienation.

On the one hand, psychedelics hold promise for personal healing and transformative individual change, and when psychedelics are eventually accepted by mainstream medicine, they will likely impact mental health outcomes for the better. But the broken systems highlighted by the coronavirus pandemic offer insight into why mental health has reached epidemic proportions in the first place.

Plus Three is joined by author and host of the Team Human podcast, Douglas Rushkoff, to discuss some of the parallel trajectories between psychedelic and digital mainstreaming. Will COVID-19 be to psychedelics as 9/11 was to surveillance capitalism? September 11th became the excuse to implement a surveillance state and surrender digital technologies to corporations. Will we see psychedelic medicines become the go-to recovery option for COVID-related mental health fallout? We also explore what a true psychedelic renaissance might look like.

Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.

In this episode, we explore the implications of MAPS’ main political strategy: demonstrating affinity for and utility to the police, the military, the far right, and individuals who have repeatedly upheld violent white supremacism. Unpacking a recent article by David Nickles, we examine the “ends justifies the means” logic that has become pervasive in psychedelic research.

In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.

Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.